All posts by: Michael Zand

Immunotherapy against bee stings in some cases incomplete
Science Daily
This is where allergen-specific immunotherapy, commonly known as allergy shots, can help. The treatment involves injecting very small doses of the venom under the patient’s skin. The idea is to force the body to become accustomed to the poison and …
Study finds immunotherapy against bee stings incompleteUPI.com

all 2 news articles »

Caribou Bioscience’s CEO on CRISPR’s legal and ethical challenges
TechCrunch
Caribou Bioscience co-founder and CEO Rachel Haurwitz joined us onstage at Disrupt this morning to help unpack some of the myriad complexities around her company’s pioneering work in the field of CRISPR biology. The gene editing tool has been the …

Design of a promising gene therapy method to treat Wilson’s disease
EurekAlert (press release)
Pamplona (Spain), May 16. Scientists at the Center for Applied Medical Research (CIMA) at the University of Navarra (Spain) have designed a promising gene therapy method to treat Wilson’s disease, a rare pathology caused by the lack of or malfunction …

Geneticists Enlist Engineered Virus and CRISPR to Battle Citrus Disease
Scientific American
Other projects aim to edit the genome of citrus trees using CRISPR–Cas9 to make them more resistant to the pest, or engineer trees to express defence genes or short RNA molecules that prevent disease transmission. Local growers have also helped to fund …

and more »

What Slate Readers Think About Synthetic Biology
Slate Magazine (blog)
Our latest Futurography unit focused on synthetic biology. We published articles on the regulatory status of the field, the possible militarization of the natural world, and even synthetic biology’s relationship to queer theory. But we’re also …

FDA Grants Fast Track Designation to Gene Therapy for Hemophilia A Patients
Rare Disease Report
Earlier today, Sangamo Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to the company’s clinical stage gene therapy candidate for hemophilia A patients – SB-525. Hemophilia A is the effect of …
FDA Grants Fast Track Designation to Sangamo’s Hemophilia A Gene TherapyDrug Discovery & Development
Novel Hemophilia A Gene Therapy Gets Fast Track StatusMonthly Prescribing Reference (registration)
FDA grants fast track designation to SB-525 for hemophilia AHealio
PR Newswire (press release) –Schaeffers Research (blog) –CNA Finance (press release)
all 81 news articles »